Ana Sandoiu, MA Author Ana Sandoiu is a freelance medical copywriter, editor, and health journalist with a decade of experience in content creation
This suggests that adiponectin may function as a unique predictor of increased fracture risk specifically in the male sex
In the Notes to Pharmacy section, a provider may write, d/c amlodipine. This means amlodipine is to be discontinued
In a culture obsessed with weight and food, some patients find that GLP-1s provide a welcome, healthy break from food noise and allow them to focus their attention elsewhere
C., and Toker, A
These effects may be more pronounced in patients with altered gastric anatomy Pancreatitis risk : Patients should be informed about symptoms of acute pancreatitis (severe abdominal pain, sometimes radiating to the back, with vomiting) and seek immediate medical attention if these occur Gallbladder disease : Increased risk of gallstones and gallbladder-related problems, particularly with substantial weight loss Dehydration and acute kidney injury : Reduced fluid intake combined with gastrointestinal side effects may increase risk of dehydration Nutritional concerns : The combination of reduced stomach capacity and appetite suppression may increase the risk of nutritional deficiencies, particularly protein, vitamin B12, iron, and calcium Hypoglycaemia risk : Especially in patients taking diabetes medications, careful monitoring and dose adjustment may be necessary Diabetic retinopathy : Patients with diabetes should have appropriate eye screening, as rapid improvement in glucose control may temporarily worsen retinopathy Medication absorption : GLP-1 receptor agonists may affect absorption of oral medications due to delayed gastric emptying Pregnancy and contraception : These medications are not recommended during pregnancy or breastfeeding
